- Home
- HFFG vs GNFT Comparison
HFFG vs GNFT Comparison
Compare HFFG & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- GNFT
- Stock Information
- Founded
- HFFG 1997
- GNFT 1999
- Country
- HFFG United States
- GNFT France
- Employees
- HFFG N/A
- GNFT N/A
- Industry
- HFFG Food Distributors
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HFFG Consumer Discretionary
- GNFT Health Care
- Exchange
- HFFG Nasdaq
- GNFT Nasdaq
- Market Cap
- HFFG 208.3M
- GNFT 186.3M
- IPO Year
- HFFG N/A
- GNFT 2019
- Fundamental
- Price
- HFFG $3.26
- GNFT $3.75
- Analyst Decision
- HFFG
- GNFT Strong Buy
- Analyst Count
- HFFG 0
- GNFT 1
- Target Price
- HFFG N/A
- GNFT $13.00
- AVG Volume (30 Days)
- HFFG 69.4K
- GNFT 3.8K
- Earning Date
- HFFG 08-05-2025
- GNFT 04-24-2025
- Dividend Yield
- HFFG N/A
- GNFT N/A
- EPS Growth
- HFFG N/A
- GNFT N/A
- EPS
- HFFG N/A
- GNFT 0.03
- Revenue
- HFFG $1,204,441,000.00
- GNFT $73,187,701.00
- Revenue This Year
- HFFG $4.27
- GNFT $15.98
- Revenue Next Year
- HFFG $4.47
- GNFT N/A
- P/E Ratio
- HFFG N/A
- GNFT $120.71
- Revenue Growth
- HFFG 4.71
- GNFT 105.01
- 52 Week Low
- HFFG $1.70
- GNFT $2.55
- 52 Week High
- HFFG $4.93
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- HFFG 43.56
- GNFT 44.52
- Support Level
- HFFG $3.22
- GNFT $3.44
- Resistance Level
- HFFG $3.32
- GNFT $3.81
- Average True Range (ATR)
- HFFG 0.19
- GNFT 0.17
- MACD
- HFFG 0.03
- GNFT -0.00
- Stochastic Oscillator
- HFFG 49.50
- GNFT 56.65
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.